BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38109505)

  • 1. Simultaneous UPLC Assay for Oxitropium Bromide and Formoterol Fumarate Dihydrate in Pressurized Metered Dose Inhaler Products for Chronic Obstructive Pulmonary Disease.
    Seckin S; Saglik Aslan S
    J AOAC Int; 2024 Mar; 107(2):242-247. PubMed ID: 38109505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Rapid, Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Formoterol Fumarate, Tiotropium Bromide, and Ciclesonide in a Pulmonary Drug Product.
    Trivedi RK; Chendake DS; Patel MC
    Sci Pharm; 2012; 80(3):591-603. PubMed ID: 23008808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
    Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive and robust methods for simultaneous determination of beclomethasone dipropionate and formoterol fumarate dihydrate in rotacaps.
    Parmar VK; Patel HN; Patel BK
    J Chromatogr Sci; 2014; 52(10):1255-66. PubMed ID: 24515312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple analytical methods for determination of formoterol and glycopyrronium simultaneously in their novel combined metered dose inhaler.
    Salem YA; Hammouda MEA; Abu El-Enin MA; El-Ashry SM
    BMC Chem; 2019 Dec; 13(1):75. PubMed ID: 31384822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Determination of Related Substances in Formoterol Fumarate and Tiotropium in Tiomate Transcaps
    Gondhale PS; Varghese Cheriyan B
    Turk J Pharm Sci; 2022 Feb; 19(1):35-47. PubMed ID: 35227048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial.
    Tashkin DP; Rennard SI; Martin P; Ramachandran S; Martin UJ; Silkoff PE; Goldman M
    Drugs; 2008; 68(14):1975-2000. PubMed ID: 18778120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous Determination of Formoterol Fumarate and Budesonide Epimers in Metered Dose Inhaler Using Ion-Pair Chromatography.
    Salem YA; Shaldam MA; El-Sherbiny DT; El-Wasseef DR; El-Ashry SM
    J Chromatogr Sci; 2017 Nov; 55(10):1013-1020. PubMed ID: 28977479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
    Cazzola M; Di Perna F; Noschese P; Vinciguerra A; Calderaro F; Girbino G; Matera MG
    Eur Respir J; 1998 Jun; 11(6):1337-41. PubMed ID: 9657576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
    Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler.
    Dhillon S; Keating GM
    Drugs; 2006; 66(11):1475-83; discussion 1484-5. PubMed ID: 16906779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial.
    Rennard SI; Tashkin DP; McElhattan J; Goldman M; Ramachandran S; Martin UJ; Silkoff PE
    Drugs; 2009; 69(5):549-65. PubMed ID: 19368417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a RP-HPLC method for the assay of formoterol and its related substances in formoterol fumarate dihydrate drug substance.
    Akapo SO; Asif M
    J Pharm Biomed Anal; 2003 Dec; 33(5):935-45. PubMed ID: 14656584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in COPD.
    Cazzola M; Matera MG; Di Perna E; Califano C; D'Amato M; Mazzarella G
    Respir Med; 1999 Dec; 93(12):909-11. PubMed ID: 10653054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease.
    Cazzola M; D'Amato M; Califano C; Di Perna F; Calderaro E; Matera MG; D'Amato G
    Clin Ther; 2002 Apr; 24(4):595-604. PubMed ID: 12017404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromatographic Techniques for Assessment of Bisoprolol Fumarate and Perindopril Arginine in Solid Formulations under Various Stress Conditions and Application to Six Sigma, Content Uniformity, and Comparative Dissolution Approaches.
    Mahmoud OA; Omran AA; Binsaleh AY; Almalki MA; Mohamed MA
    J AOAC Int; 2023 Sep; 106(5):1165-1179. PubMed ID: 37341634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma.
    Morice AH; Peterson S; Beckman O; Osmanliev D
    Int J Clin Pract; 2007 Nov; 61(11):1874-83. PubMed ID: 17887990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental benefit of adding oxitropium bromide to formoterol in patients with stable COPD.
    Cazzola M; Di Perna F; Califano C; Vinciguerra A; D'Amato M
    Pulm Pharmacol Ther; 1999; 12(4):267-71. PubMed ID: 10501652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
    Corren J; Korenblat PE; Miller CJ; O'Brien CD; Mezzanotte WS
    Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.